What’s New

Article Dec 20, 2024
Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv

Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or…

Interview Dec 4, 2024
Spatial Transcriptomics Expertise: An Interview With Dr. Wendy Teft

Wendy Teft, PhD, Vice President of Precision Medicine and Head of AcelaBio AcelaBio, Alimentiv’s state-of-the-art specialty laboratory, specializes in delivering high-quality histopathology and precision medicine…

Article Dec 20, 2024
Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv

Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or…

Article Nov 1, 2024
Give Your Project Lift

With A Proven Quality By Design Framework Applying our Quality By Design framework in clinical trials saves time, money, and resources. These are crucial, precious,…

Article May 30, 2024
Alimentiv DDW 2024 Presentations

If you’ve missed some of our lecture presentations and poster sessions, reach out for more information….

Article Mar 19, 2024
Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide,…

Article Jan 10, 2024
Bayesian innovations to supplement open-label trials

Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase…

Article Nov 9, 2023
2023 Size of the CRO Market

We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources….